DETAILED NOTES ON SITUS JUDI MBL77

Not all patients with CLL demand therapy. Regardless of all current advances, the iwCLL continue to suggests watchful observation for people with asymptomatic condition.86 This advice relies on no less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The